On an investment spree with billions of dollars’ worth of projects ongoing globally, Indianapolis-based Eli Lilly and Company ...

US-based pharmaceutical giant Eli Lilly is focusing on weight loss medications like Mounjaro (tirzepatide), which has proven ...

In a cinematic turn of events, a 34-year-old Brazilian man allegedly stole two wristwatches worth over Rs 3.3 lakh from a duty-free store at Kempegowda International Airport (KIA) in Bengaluru before ...

Deep-pocketed investors have adopted a bearish approach towards Eli Lilly LLY, and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this ...

Approval was based on results of the VIVID-1 study, which found that Omvoh demonstrated significant clinical remission and endoscopic response rates in patients with Crohn disease. The FDA has ...

As of Jan.1, Lilly was able to obtain first-line biologic coverage for Omvoh from two large pharmacy benefit managers, meaning it will be available on “formulary in the preferred specialty tier ...

“I have total confidence in the rest of the girls.” That confidence proved well founded Wednesday as Sam Kerry and Kyra Lilly stepped up offensively and the Knights’ press wreaked havoc as Kaneland ...

Bengaluru, popularly known as Bangalore, is a hi-tech city that is also known as the ‘Silicon Valley of India’ due to wide spread presence of IT industry. Bangalore offers high career opportunities ...

Eli Lilly said it received Food and Drug Administration approval for its treatment for moderate to severely-active Crohn's disease, an inflammatory bowel disease that causes chronic abdominal pain.

Eli Lilly (LLY) announced that the FDA has approved Omvoh for the treatment of moderately to severely active Crohn’s disease in adults. Omvoh is now approved in the U.S. for two types of ...